ReCode Therapeutics

About:

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.

Website: https://recodetx.com

Twitter/X: recodetx

Top Investors: OrbiMed, EcoR1 Capital, OUP (Osage University Partners), MPM Capital, Matrix Capital Management

Description:

ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics. Its selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a genetic medicines technology that enables precise delivery to target organs and cells beyond the liver. The company aims to leverage innovative technologies to provide solutions for individuals affected by genetic diseases.